New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2012
10:16 EDTDUK, BSX, KRC, WSM, IGT, DELL, CUBE, AGU, WWAV, ESS, TOT, FNSR, DECK, CSC, THOR, DLR, NI, EVOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Agrium (AGU) upgraded to Overweight from Neutral at Piper Jaffray... Boston Scientific (BSX) upgraded to Outperform from Market Perform at JMP Securities... CSC (CSC) upgraded to Outperform from Neutral at Cowen... CubeSmart (CUBE) upgraded to Outperform from Neutral at RW Baird... Deckers Outdoor (DECK) upgraded to Buy from Neutral at Sterne Agee... Dell (DELL) upgraded to Buy from Sell at Goldman... Duke Energy (DUK) upgraded to Overweight from Equal Weight at Barclays... Eaton Vance (EV) upgraded to Neutral from Sell at Goldman... Ericsson (ERIC) upgraded to Outperform from Sector Perform at RBC Capital... Finisar (FNSR) upgraded to Buy from Hold at Needham... International Game (IGT) upgraded to Buy from Hold at Deutsche Bank... NiSource (NI) upgraded to Overweight from Equal Weight at Barclays... Total (TOT) upgraded to Buy from Hold at Deutsche Bank... Williams-Sonoma (WSM) upgraded to Overweight from Equal Weight at Morgan Stanley... Digital Realty (DLR) upgraded to Buy from Neutral at ISI Group... Essex Property Trust (ESS) upgraded to Buy from Neutral at ISI Group... Kilroy Realty (KRC) upgraded to Buy from Neutral at ISI Group... Thoratec (THOR) upgraded to Conviction Buy from Buy at Goldman... WhiteWave Foods (WWAV) upgraded to Buy from Hold at Stifel Nicolaus.
News For AGU;BSX;CSC;CUBE;DUK;DECK;DELL;EV;FNSR;IGT;NI;TOT;WSM;DLR;ESS;KRC;THOR;WWAV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
March 18, 2015
16:18 EDTWSMWilliams-Sonoma increases quarterly dividend 2c to 35c per share
Williams-Sonoma announced that its board has authorized a 6% increase in the company’s quarterly cash dividend. The quarterly cash dividend will be increased to 35c from 33c per common share and is payable on May 28 to shareholders of record as of the close of business on April 24.
16:17 EDTWSMWilliams-Sonoma sees FY15 EPS $3.35-$3.45, consensus $3.63
Subscribe for More Information
16:16 EDTWSMWilliams-Sonoma sees Q1 EPS 40c-45c, consensus 54c
Subscribe for More Information
16:14 EDTWSMWilliams-Sonoma reports Q4 EPS ex-items $1.52, consensus $1.52
Subscribe for More Information
15:20 EDTWSMNotable companies reporting after market close
Subscribe for More Information
13:35 EDTDLRColovore announces strategic investment from Digital Realty
Subscribe for More Information
10:00 EDTNIOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Columbia Pipeline (CPPL) initiated with a Buy at Citigroup... DBV Technologies (DBVT) initiated with a Buy at H.C. Wainwright... Genocea (GNCA) initiated with an Overweight at Piper Jaffray... NiSource (NI) initiated with a Neutral at JPMorgan... On Deck Capital (ONDK) initiated with a Sell at Compass Point... Rexel (RXEEY) initiated with an Overweight at Barclays... Shutterfly (SFLY) initiated with a Buy at Axiom... Virgin America (VA) initiated with an Underperform at Credit Suisse.
07:19 EDTWSMWilliams-Sonoma volatility elevated into Q4 and outlook
Subscribe for More Information
06:32 EDTNINiSource reinstated with an Outperform at Credit Suisse
Subscribe for More Information
06:28 EDTNINiSource initiated with a Neutral at JPMorgan
Target $46.
05:39 EDTBSXSt. Jude Medical downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded St. Jude Medical (STJ) to Market Perform saying competitive pressures will drive 2015 market share losses in the company's cardiac rhythm management business, which represents 50% of total sales. Wells believes the launch of CardioMEMS will not be strong enough to offset the headwinds in CRM unit. The firm thinks Boston Scientific's (BSX) earlier than expected approval for its next generation subcutaneous implantable cardioverter-defibrillator called Emblem will drive share gains against St. Jude and Medtronic (MDT) in the single chamber ICD market. Wells cut its price target range for St. Jude shares to $69-$70 from $73-$74. The medical technology company closed yesterday down $2.01 to $65.45.
March 17, 2015
16:13 EDTBSXBoston Scientific announces FDA, CE Mark approval of EMBLEM S-ICD system
Boston Scientific has received FDA and CE Mark approval of the EMBLEM Subcutaneous Implantable Defibrillator, or S-ICD, system. The EMBLEM S-ICD System is a treatment option that provides protection for patients at risk of sudden cardiac arrest, yet leaves the heart and vasculature untouched, minimizing the risk of complications associated with conventional transvenous implantable cardioverter-defibrillators. A controlled and limited market release has begun in a small number of European centers with a broad European launch scheduled for May and subsequent U.S. launch planned for the third quarter of 2015.
10:00 EDTESSOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Aimco (AIV) initiated with an Outperform at RW Baird... Alnylam (ALNY) initiated with a Buy at Janney Capital... American Campus (ACC) initiated with a Neutral at RW Baird... AvalonBay (AVB) initiated with a Neutral at RW Baird... BE Aerospace (BEAV) initiated with a Buy at CRT Capital... BlackRock (BLK) initiated with a Buy at Argus... Camden Property (CPT) initiated with an Outperform at RW Baird... CarMax (KMX) initiated with a Buy at Evercore ISI... Central Pacific (CPF) initiated with a Neutral at Macquarie... Cognex (CGNX) initiated with a Buy at Northcoast... Education Realty (EDR) initiated with a Neutral at RW Baird... EnerSys (ENS) initiated with an Overweight at Stephens... Equity Lifestyle (ELS) initiated with an Outperform at RW Baird... Equity Residential (EQR) initiated with a Neutral at RW Baird... Essex Property Trust (ESS) initiated with a Neutral at RW Baird... Facebook (FB) initiated with a Buy at Brean Capital... Intercept (ICPT) initiated with a Hold at MLV & Co.... Isis Pharmaceuticals (ISIS) initiated with a Neutral at Janney Capital... LinkedIn (LNKD) initiated with a Sell at Brean Capital... Mid-America Apartment (MAA) initiated with an Outperform at RW Baird... NetSuite (N) initiated with a Hold at Brean Capital... Paycom (PAYC) initiated with a Buy at Brean Capital... Platform Specialty Products (PAH) initiated with a Buy at UBS... Post Properties (PPS) initiated with a Neutral at RW Baird... Salesforce.com (CRM) initiated with a Hold at Brean Capital... ServiceNow (NOW) initiated with a Buy at Brean Capital... Snap-On (SNA) initiated with a Buy at Northcoast... Sun Communities (SUI) initiated with a Neutral at RW Baird... Twitter (TWTR) initiated with a Buy at Brean Capital... UDR, Inc. (UDR) initiated with an Outperform at RW Baird... Workday (WDAY) initiated with a Hold at Brean Capital... Xplore Technologies (XPLR) initiated with a Buy at Roth Capital... Yahoo (YHOO) initiated with a Hold at Argus.
06:07 EDTESSEssex Property Trust initiated with a Neutral at RW Baird
Subscribe for More Information
March 16, 2015
13:16 EDTBSXAnalysts upbeat on results of Edwards' Sapien 3 data
The shares of Edwards Lifesciences (EW) are rising after the company released data on its Sapien 3 transcathter aortic valve over the weekend. In notes to investors today, a number of analysts were upbeat on the data. BACKGROUND: Edwards yesterday announced that high- and intermediate-risk patients treated with Sapien 3 demonstrated lower mortality rates than patients treated with previous transcathter aortic valves, or TAVR, made by the company. The patients also had excellent clinical outcomes in the other primary endpoints of stroke and paravalvular regurgitation, the company stated. Meanwhile, a five year study of patients treated with the first generation SAPIEN device showed that the patients had equivalent outcomes to traditional open-heart surgery, and no structural valve deterioration requiring intervention, the company stated. ANALYST REACTION: Edwards' Sapien 3 data was impressive, as the device showed one of the lowest stroke and mortality rates of any major TAVR study so far, Bernstein analyst Derrick Sung wrote in a note to investors earlier today. Data presented by Edwards and other companies at the American College of Cardiology, or ACC, conference this weekend caused investors and the medical community to become more optimistic about the potential for TAVR devices to replace surgical valves, Sung stated. The analyst wrote that he continues to believe that investors are underestimating the potential size of the TAVR market. Also upbeat on Edwards' data was Wells Fargo, which wrote that the data exceeded high expectations and could pressure the FDA to approve Sapien 3 for intermediate risk patients earlier than Edwards' guidance of late 2016. WHAT'S NOTABLE: Analysts were also upbeat on data reported by other companies at the ACC conference. Medtronic's (MDT) data suggested that its CoreValve Evolut-R product may be as effective as Edwards' Sapien 3, Bernstein's Sung stated. The FDA appears to have allowed Boston Scientific's (BSX) left atrial appendage closure, Watchman, to be provided to more patients than expected, research firm Stifel believes. Meanwhile, St. Jude's (STJ) CardioMEMS device yielded "impressive" mortality data, the firm added. Stifel kept Buy ratings on both Medtronic and St. Jude. PRICE ACTION: In early afternoon trading, Edwards Lifesciences climbed 9% to $147.64, Boston Scientific advanced 4% to $17.27, St. Jude added 2% to $67.55, and Medtronic rose 1.3% to $77.50.
11:11 EDTTOTOPEC sees oil prices to hit U.S. oil output by late 2015, Reuters says
Subscribe for More Information
09:22 EDTBSXOn The Fly: Pre-market Movers
Subscribe for More Information
07:58 EDTESSEquity Residential, Essex Property Trust price targets raised at Jefferies
Subscribe for More Information
07:25 EDTBSXBoston Scientific Watchman indication 'very favorable,' says Bernstein
Subscribe for More Information
05:56 EDTTOTTotal looking to sell 20% stake in North Sea gasfield, Financial Times reports
Total is auctioning a stake in a North Sea gasfield, reports the Financial Times. The company is looking to sell a 20% stake in Laggan-Tormore, a deepwater project considered to be a prime asset in the energy group's portfolio. Total would continue to operate the field, with peak production expanded to be 500m cubic feet a day. Reference Link
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use